COHBAR
CohBar is a clinical-stage biotechnology company that focuses on the research and development of mitochondria based therapeutics. It has developed proprietary mitochondria based therapeutic (MBT) platform technology, using cell-based assays and animal models of disease, to rapidly identify naturally occurring MDPs with promising biological activity. The company was founded in 2007 and is headquartered in Menlo Park, California.
COHBAR
Social Links:
Industry:
Biotechnology Developer Platform Therapeutics
Founded:
2007-01-01
Address:
Menlo Park, California, United States
Country:
United States
Website Url:
http://www.cohbar.com
Total Employee:
1+
Status:
Active
Contact:
4153818980
Email Addresses:
[email protected]
Total Funding:
24.55 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon Apache Microsoft Exchange Online Amazon Office 365 Mail
Similar Organizations
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
Aura Biosciences
Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor targeted pseudovirions.
Axcella
Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.
InQ Biosciences
InQ Biosciences provides integrated cell growth and cell analysis systems for research and development in the cell and tissue growth sector.
Current Employees Featured
Founder
Stock Details
Official Site Inspections
http://www.cohbar.com Semrush global rank: 3.63 M Semrush visits lastest month: 3.92 K
- Host name: ec2-174-129-30-187.compute-1.amazonaws.com
- IP address: 174.129.30.187
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
More informations about "CohBar"
About :: CohBar, Inc. (CWBR)
CohBar is a clinical-stage biotechnology company exploiting the power of the mitochondria and its encoded peptides to develop potential breakthrough therapeutics targeting chronic and age …See details»
Company Information :: CohBar, Inc. (CWBR)
Company Contact CohBar, Inc. 1455 Adams Drive Suite 1308 Menlo Park, CA 94025 T: (650) 446-7888 [email protected]See details»
CohBar - Crunchbase Company Profile & Funding
CohBar is a clinical-stage biotechnology company that focuses on the research and development of mitochondria based therapeutics. It has developed proprietary mitochondria based therapeutic (MBT) platform technology, using …See details»
CohBar - MitoWorld
CohBar is a clinical-stage biotechnology company exploiting the power of the mitochondria and its encoded peptides to develop potential breakthrough therapeutics targeting chronic and age …See details»
CohBar, Inc. (CWBR) Company Profile & Overview - Stock Analysis
2 days ago CohBar, Inc., a clinical stage biotechnology company, develops mitochondria and peptides based therapeutics for the treatment of chronic and age-related diseases. It develops …See details»
CohBar, Inc. - LinkedIn
CohBar, Inc. | 1,560 followers on LinkedIn. CohBar is a clinical-stage biotechnology company leveraging the power of the mitochondria and the peptides encoded in its genome to develop potential ...See details»
CohBar, Inc. and Morphogenesis, Inc. Enter into Definitive Merger ...
May 23, 2023 About the Proposed Transaction, Management & Organization. ... About CohBar. CohBar (NASDAQ: CWBR) is a clinical-stage biotechnology company leveraging the power of …See details»
CohBar Company Profile - Office Locations, Competitors, Revenue …
CohBar is a clinical-stage biotechnology company focused on the research and development of mitochondria based therapeutics. It aims to treat a range of diseases associated with aging …See details»
CohBar Announces Changes to its Board of Directors and R&D …
Dec 17, 2021 Founding board members transition to reconstituted Scientific Advisory Board Kent Grindstaff, Ph.D. appointed as Senior Vice President of Research MENLO PARK, Calif., …See details»
CohBar Provides Update on the Phase 1a/1b Clinical Trial for …
MENLO PARK, Calif., July 14, 2021 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics to treat …See details»
CohBar Announces Changes to its Board of Directors and R&D …
Dec 17, 2021 CohBar (NASDAQ: CWBR) is a clinical stage biotechnology company focused on the research and development of mitochondria based therapeutics, an emerging class of …See details»
CohBar - VentureRadar
" CohBar is a clinical stage biotechnology company focused on the research and development of mitochondria based therapeutics, an emerging class of drugs for the treatment of chronic and …See details»
CohBar Reports Fourth Quarter and Full-Year 2021 Financial …
Mar 29, 2022 CohBar, Inc. Conference call and webcast at 5:00 p.m. ET today, March 29, 2022. MENLO PARK, Calif., March 29, 2022 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: …See details»
CohBar - The Pioneer In Mitochondrial Drugs - Seeking Alpha
CohBar is only in a Phase 1a/b safety and efficacy trial. These days, preclinical work has gotten so good that very few drugs fail their Phase 1a human safety trial. However, it is still true that ...See details»
CohBar Announces Extension of Nasdaq Compliance Period and …
MENLO PARK, Calif., May 12, 2022 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR) (the “Company”), a clinical stage biotechnology company leveraging the power of the …See details»
CohBar’s CEO to Participate in Upcoming BIO Webinar - Yahoo …
MENLO PARK, Calif., Nov. 29, 2021 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics to treat …See details»
CohBar Announces Positive Topline Results from the Phase
Aug 10, 2021 CohBar (NASDAQ: CWBR) is a clinical stage biotechnology company focused on the research and development of mitochondria based therapeutics, an emerging class of …See details»
CohBar Reports Fourth Quarter and Full-Year 2021 Financial …
Mar 29, 2022 Conference call and webcast at 5:00 p.m. ET today, March 29, 2022. MENLO PARK, Calif., March 29, 2022 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a …See details»
CohBar Reports Third Quarter 2022 Financial Results and …
Nov 8, 2022 Conference call and webcast today at 5:00 p.m. ET, November 8, 2022. MENLO PARK, Calif., Nov. 08, 2022 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a …See details»